Frank Rimerman Advisors LLC Has $72,000 Position in Medical Properties Trust, Inc. (NYSE:MPW)

Frank Rimerman Advisors LLC boosted its holdings in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 63.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,148 shares of the real estate investment trust’s stock after buying an additional 7,070 shares during the period. Frank Rimerman Advisors LLC’s holdings in Medical Properties Trust were worth $72,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Quadrature Capital Ltd acquired a new stake in Medical Properties Trust during the third quarter worth $927,000. JPMorgan Chase & Co. boosted its stake in shares of Medical Properties Trust by 21.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,704,785 shares of the real estate investment trust’s stock valued at $9,973,000 after purchasing an additional 303,628 shares in the last quarter. Versor Investments LP boosted its stake in shares of Medical Properties Trust by 192.3% in the 4th quarter. Versor Investments LP now owns 285,000 shares of the real estate investment trust’s stock valued at $1,126,000 after purchasing an additional 187,500 shares in the last quarter. Y Intercept Hong Kong Ltd boosted its stake in shares of Medical Properties Trust by 506.8% in the 4th quarter. Y Intercept Hong Kong Ltd now owns 63,207 shares of the real estate investment trust’s stock valued at $250,000 after purchasing an additional 52,790 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Medical Properties Trust by 353.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust’s stock valued at $20,625,000 after purchasing an additional 2,748,245 shares in the last quarter. Institutional investors and hedge funds own 71.79% of the company’s stock.

Insider Buying and Selling at Medical Properties Trust

In other news, CAO James Kevin Hanna sold 11,641 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $3.72, for a total value of $43,304.52. Following the transaction, the chief accounting officer now directly owns 366,913 shares in the company, valued at $1,364,916.36. This trade represents a 3.08 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.53% of the company’s stock.

Medical Properties Trust Stock Performance

Medical Properties Trust stock opened at $6.04 on Tuesday. Medical Properties Trust, Inc. has a 1 year low of $3.51 and a 1 year high of $6.55. The company’s 50-day moving average is $4.83 and its two-hundred day moving average is $4.74. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69. The company has a market cap of $3.62 billion, a PE ratio of -1.43, a PEG ratio of 1.01 and a beta of 1.32.

Medical Properties Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 10th. Shareholders of record on Monday, March 10th will be issued a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 5.30%. The ex-dividend date is Monday, March 10th. Medical Properties Trust’s dividend payout ratio is presently -8.42%.

Wall Street Analysts Forecast Growth

MPW has been the topic of several recent analyst reports. Truist Financial reduced their target price on shares of Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating on the stock in a research note on Thursday, December 19th. StockNews.com upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Monday, March 3rd. BNP Paribas upgraded shares of Medical Properties Trust from a “neutral” rating to an “outperform” rating and boosted their target price for the company from $5.00 to $9.00 in a research note on Wednesday, March 12th. Royal Bank of Canada lifted their price target on Medical Properties Trust from $4.00 to $5.00 and gave the company a “sector perform” rating in a report on Monday, March 10th. Finally, Wells Fargo & Company lifted their price target on Medical Properties Trust from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $5.64.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.